Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin C Pritchard

Showing results (41-50 of 172) with videos related to

Pageof 18
Sort By:
JCO Precision Oncology|September 11, 2020
Polyclonal <i>BRCA2</i> Reversion Mutations Detected in Circulating Tumor DNA After Platinum Chemotherapy in a Patient With Metastatic Prostate CancerHeather H Cheng, Stephen J Salipante, Peter S Nelson, et al.
Histopathology|January 13, 2019
DNA damage repair alterations are frequent in prostatic adenocarcinomas with focal pleomorphic giant-cell featuresTamara L Lotan, Harsimar B Kaur, Abdullah M Alharbi, et al.
Clinical Chemistry|July 3, 2014
Microsatellite instability detection by next generation sequencingStephen J Salipante, Sheena M Scroggins, Heather L Hampel, et al.
The Journal of Molecular Diagnostics : JMD|May 25, 2018
Efficient Detection of Copy Number Mutations in PMS2 Exons with a Close HomologDaniel S Herman, Christina Smith, Chang Liu, et al.
Human Pathology|November 30, 2019
MSH6 immunohistochemical heterogeneity in colorectal cancer: comparative sequencing from different tumor areasWei Chen, Rachel Pearlman, Heather Hampel, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 27, 2013
A mosaic PTEN mutation causing Cowden syndrome identified by deep sequencingColin C Pritchard, Christina Smith, Tatyana Marushchak, et al.
Journal for Immunotherapy of Cancer|May 15, 2018
Significance and implications of FDA approval of pembrolizumab for biomarker-defined diseaseMichael M Boyiadzis, John M Kirkwood, John L Marshall, et al.
Gastroenterology|September 8, 2014
Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutationsSigurdis Haraldsdottir, Heather Hampel, Jerneja Tomsic, et al.
Human Pathology|June 9, 2014
Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeuticsGeorge Jour, John D Scarborough, Robin L Jones, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 4, 2018
Two-stain immunohistochemical screening for Lynch syndrome in colorectal cancer may fail to detect mismatch repair deficiencyRachel Pearlman, Michael Markow, Deborah Knight, et al.
Pageof 18

Showing results (41-50 of 172) with videos related to

Sort By:
Pageof 18
JCO Precision Oncology|September 11, 2020
Polyclonal <i>BRCA2</i> Reversion Mutations Detected in Circulating Tumor DNA After Platinum Chemotherapy in a Patient With Metastatic Prostate CancerHeather H Cheng, Stephen J Salipante, Peter S Nelson, et al.
Histopathology|January 13, 2019
DNA damage repair alterations are frequent in prostatic adenocarcinomas with focal pleomorphic giant-cell featuresTamara L Lotan, Harsimar B Kaur, Abdullah M Alharbi, et al.
Clinical Chemistry|July 3, 2014
Microsatellite instability detection by next generation sequencingStephen J Salipante, Sheena M Scroggins, Heather L Hampel, et al.
The Journal of Molecular Diagnostics : JMD|May 25, 2018
Efficient Detection of Copy Number Mutations in PMS2 Exons with a Close HomologDaniel S Herman, Christina Smith, Chang Liu, et al.
Human Pathology|November 30, 2019
MSH6 immunohistochemical heterogeneity in colorectal cancer: comparative sequencing from different tumor areasWei Chen, Rachel Pearlman, Heather Hampel, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 27, 2013
A mosaic PTEN mutation causing Cowden syndrome identified by deep sequencingColin C Pritchard, Christina Smith, Tatyana Marushchak, et al.
Journal for Immunotherapy of Cancer|May 15, 2018
Significance and implications of FDA approval of pembrolizumab for biomarker-defined diseaseMichael M Boyiadzis, John M Kirkwood, John L Marshall, et al.
Gastroenterology|September 8, 2014
Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutationsSigurdis Haraldsdottir, Heather Hampel, Jerneja Tomsic, et al.
Human Pathology|June 9, 2014
Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeuticsGeorge Jour, John D Scarborough, Robin L Jones, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 4, 2018
Two-stain immunohistochemical screening for Lynch syndrome in colorectal cancer may fail to detect mismatch repair deficiencyRachel Pearlman, Michael Markow, Deborah Knight, et al.
Pageof 18